Integra LifeSciences Holdings Corporation Stock
Stocks
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
05:00:00 03/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 13.61 USD | +6.75% |
|
+12.48% | +9.58% |
| 10-27 | UBS Adjusts Integra LifeSciences Price Target to $14 From $19, Maintains Neutral Rating | MT |
| 10-23 | Truist Adjusts Price Target on Integra LifeSciences to $13 From $15, Maintains Hold Rating | MT |
| Market Cap | 1.06B 945M 868M 789M 1.48B 100B 1.51B 10.36B 4.18B 52.91B 3.97B 3.89B 167B | P/E 2026 * |
27.8x | P/E 2027 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.87B 2.56B 2.35B 2.14B 4B 271B 4.08B 28.05B 11.31B 143B 10.76B 10.53B 452B | EV / Sales 2026 * |
1.74x | EV / Sales 2027 * | 1.41x |
| Free-Float |
72.33% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IART | Delayed | |
CBOE
| IART | Real-time | |
|
Tradegate
| IL3 | Real-time | |
|
Boerse Muenchen
| IL3 | Real-time | |
|
Deutsche Boerse AG
| IL3 | Delayed | |
|
Börse Stuttgart
| IL3 | Delayed | |
|
Berne S.E.
| IL3 | End-of-day quote |
Last Transcript: Integra LifeSciences Holdings Corporation
| 1 day | +6.75% | ||
| 1 week | +12.48% | ||
| Current month | +6.75% | ||
| 1 month | +7.33% | ||
| 3 months | -18.26% | ||
| 6 months | +24.29% | ||
| Current year | +9.58% |
| 1 week | 11.93 |  | 13.97 |
| 1 month | 11.57 | | 14.28 |
| Current year | 8.7 | | 20.49 |
| 1 year | 8.7 | | 20.49 |
| 3 years | 8.7 | | 45.42 |
| 5 years | 8.7 | | 73.51 |
| 10 years | 8.7 | | 77.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stuart Essig
CEO | Chief Executive Officer | 64 | 01/05/2026 |
Lea Knight
DFI | Director of Finance/CFO | 54 | 28/06/2023 |
Teshtar Elavia
CTO | Chief Tech/Sci/R&D Officer | - | 17/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Stuart Essig
CHM | Chairman | 64 | 03/01/2012 |
Keith Bradley
BRD | Director/Board Member | 81 | 01/01/1992 |
Christian Schade
BRD | Director/Board Member | 65 | 01/01/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/10/26 | Other | Executive/Senior Manager | 67,801 | 0.0871% | ||
| 17/9/26 | Other | Company Secretary | 26,838 | 0.0345% | ||
| 1/9/26 | Tax | Head of Human Resources | -1,455 | 0.0019% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.75% | +12.48% | +13.32% | -63.99% | 1.06B | |
| +3.73% | +5.03% | -10.89% | +14.80% | 191B | |
| +2.85% | +4.75% | +9.47% | +37.73% | 122B | |
| +5.12% | +0.22% | -13.88% | +10.27% | 117B | |
| +1.41% | +6.80% | -41.10% | +6.45% | 96.21B | |
| +2.12% | +2.38% | +0.01% | +75.79% | 64.47B | |
| -5.48% | -5.11% | -1.24% | +61.88% | 52.51B | |
| +0.36% | +1.13% | +11.13% | -22.40% | 54.1B | |
| +21.85% | +17.79% | +6.69% | +60.13% | 52.91B | |
| +2.23% | +4.24% | +1.04% | -8.32% | 35.65B | |
| Average | +4.09% | +4.73% | -2.54% | +17.23% | 78.59B | |
| Weighted average by Cap. | +3.69% | +3.96% | -7.07% | +24.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.64B 1.47B 1.35B 1.23B 2.3B 156B 2.34B 16.09B 6.49B 82.16B 6.17B 6.04B 259B | 1.67B 1.5B 1.37B 1.25B 2.34B 159B 2.39B 16.39B 6.61B 83.69B 6.29B 6.15B 264B |
| Net income | 35.57M 31.76M 29.14M 26.51M 49.7M 3.37B 50.69M 348M 140M 1.78B 134M 131M 5.61B | 69.57M 62.12M 57M 51.85M 97.21M 6.59B 99.15M 681M 274M 3.48B 261M 256M 10.98B |
| Net Debt | 1.81B 1.61B 1.48B 1.35B 2.53B 171B 2.58B 17.69B 7.13B 90.31B 6.78B 6.64B 285B | 1.31B 1.17B 1.07B 973M 1.82B 124B 1.86B 12.78B 5.15B 65.25B 4.9B 4.8B 206B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | US$13.61 | +6.75% | 1,505,251 |
| 30/10/26 | US$12.75 | -0.62% | 1,038,771 |
| 29/10/26 | US$12.83 | +4.82% | 1,188,113 |
| 28/10/26 | US$12.24 | +2.09% | 1,789,034 |
| 27/10/26 | US$11.99 | -0.91% | 1,431,837 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IART Stock
Select your edition
All financial news and data tailored to specific country editions
